Brooklyn Investment Group’s AbbVie ABBV Stock Holding History

Brooklyn Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.7M	Buy	63,195 +17,590	+39%	+$3.9M	0.43%	30
2025 Q4	$10.5M	Buy	45,605 +20,811	+84%	+$4.74M	0.49%	29
2025 Q3	$4.43M	Sell	24,794 -806	-3%	-$164K	0.6%	27
2025 Q2	$4.57M	Buy	25,600 +5,021	+24%	+$933K	0.6%	23
2025 Q1	$4.31M	Buy	20,579 +5,241	+34%	+$1.02M	0.93%	17
2024 Q4	$2.73M	Buy	15,338 +3,502	+30%	+$644K	0.81%	23
2024 Q3	$2.34M	Buy	11,836 +1,779	+18%	+$332K	0.77%	24
2024 Q2	$1.82M	Hold	10,057	–	–	0.78%	27
2024 Q1	$1.82M	Buy	10,057 +264	+3%	+$45.5K	0.78%	27
2023 Q4	$1.52M	Buy	+9,793	New	+$1.43M	0.72%	28

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Brooklyn Investment Group's ABBV Position: Q1 2026 in Review

Brooklyn Investment Group increased its AbbVie (ABBV) stake by 39% in Q1 2026, buying an estimated $3.9M and bringing the position to 63,195 shares worth $13.7M. The position accounts for 0.43% of the portfolio, ranked #30.

Brooklyn Investment Group first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Brooklyn Investment Group held 63,195 shares of AbbVie worth $13.7M as of Q1 2026.
Brooklyn Investment Group bought 17,590 AbbVie shares in Q1 2026, an estimated $3.9M.
AbbVie made up 0.43% of Brooklyn Investment Group's portfolio in Q1 2026, its #30 holding.
Brooklyn Investment Group first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.